Related Experiment Video

Updated: Jul 17, 2026

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
06:51

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma

R B Jia1, P Zhang, Y X Zhou

  • 1Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Ophthalmic Research
|February 8, 2007
PubMed

Insights

Targeting vascular endothelial growth factor (VEGF) with RNA interference (RNAi) effectively inhibited retinoblastoma angiogenesis and tumor growth. This study demonstrates RNAi

Area of Science:

  • Oncology
  • Molecular Biology
  • Ophthalmology

Background:

  • Vascular endothelial growth factor (VEGF) is crucial for tumor angiogenesis and retinoblastoma neovascularization.
  • Understanding VEGF's role is key to developing targeted therapies for retinoblastoma.

Purpose of the Study:

  • To investigate the efficacy of RNA interference (RNAi) targeting VEGF in inhibiting retinoblastoma angiogenesis and tumor growth.
  • To evaluate VEGF-targeted small interfering RNA (siRNA) as a potential therapeutic strategy for retinoblastoma.

Main Methods:

  • Stable transfection of retinoblastoma cell lines (SO-RB50, HXO-RB44) with VEGF-targeted siRNA expression plasmids.
  • Quantification of VEGF expression using real-time PCR, ELISA, and Western blot.
  • Assessment of tumor angiogenesis via CD34 immunohistochemistry and tumor growth in a xenograft model.

Main Results:

  • VEGF-targeted siRNA significantly inhibited VEGF expression at both mRNA and protein levels in cell lines and xenografts.
  • Suppression of VEGF led to reduced tumor angiogenesis and tumor growth in the SO-RB50 xenograft model.
  • Control transfections showed no significant effects on VEGF expression or tumor parameters.

Conclusions:

  • VEGF-targeted RNAi demonstrates a significant suppressive effect on retinoblastoma angiogenesis and tumor progression.
  • This RNAi-based approach represents a promising novel therapeutic strategy for the clinical management of retinoblastoma.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...